PMA device
Coretherm System Microwave Thermotherapy
Prostalund AB · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ, Class III) · First FDA decision Nov 5, 2004, newest Jun 8, 2009Enlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Coretherm"
MAUDE reports
0
Brand "Coretherm", since 2015
PubMed studies
17
Mentioning "Coretherm"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Coretherm System Microwave Thermotherapy
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- CORETHERM SYSTEM MICROWAVE THERMOTHERAPYPMA supplement
P010055-S006 · Decided Jun 8, 2009 · 67 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- CORETHERM SYSTEM MICROWAVE THERMOTHERAPYPMA supplement
P010055-S005 · Decided May 21, 2009 · 49 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- CORETHERM SYSTEM MICROWAVE THERMOTHERAPYPMA supplement
P010055-S002 · Decided Nov 5, 2004 · 36 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Coretherm", any status and sponsor, newest update first.
No registered device study names "Coretherm".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Coretherm", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MEQ
3 reports: 1 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Coretherm"[tiab]. The summary above synthesizes these.
- Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
Mattiasson A, Wagrell L, Schelin S, et al. · Urology · 2007Comparative Study, Multicenter Study
- Transurethral microwave thermotherapy of the prostate--evaluation with MRI and analysis of parameters relevant to outcome.
Vesely S, Müller M, Knutson T, et al. · Scand J Urol Nephrol · 2008Research Support, Non-U.S. Gov't
- Treatment with CoreTherm in 570 patients with prostate volumes of 80-366ߙml: an evaluation of short- and long-term retreatment risk.
Stenmark F, Brudin L, Kjölhede H, et al. · Scand J Urol · 2022
- High-energy feedback microwave thermotherapy and intraprostatic injections of mepivacaine and adrenaline: an evaluation of calculated cell kill accuracy and responder rate.
Stenmark F, Brudin L, Stranne J, et al. · Scand J Urol · 2014Evaluation Study, Research Support, Non-U.S. Gov't
- Prostate volume and age are predictors of energy delivery using the CoreTherm Concept in patients with LUTS/BPO: a study on thermal dose.
Stenmark F, Brudin L, Kjölhede H, et al. · Scand J Urol · 2020
- State-of-the-art in minimally invasive treatments for benign prostatic obstruction.
Grossmann NC, Berjaoui MB, Choudhary O, et al. · Investig Clin Urol · 2026Review, Research Support, Non-U.S. Gov't
- Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping.
Huidobro C, Bolmsjö M, Larson T, et al. · J Urol · 2004
- High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis.
Kaye JD, Smith AD, Badlani GH, et al. · J Endourol · 2008Comparative Study, Meta-Analysis
- Multicenter initial U.S. experience with CoreTherm-monitored feedback transurethral microwave thermotherapy for individualized treatment of patients with symptomatic benign prostatic hyperplasia.
David RD, Grunberger I, Shore N, et al. · J Endourol · 2004Multicenter Study
- Long-term treatment outcomes of CoreTherm microwave feedback thermotherapy.
Eisenberg ER, Badlani GH · Curr Urol Rep · 2004Review
- Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
Wagrell L, Schelin S, Nordling J, et al. · Urology · 2004Clinical Trial, Comparative Study
- Transurethral microwave thermotherapy treatment of chronic urinary retention in patients unsuitable for surgery.
Aagaard MF, Niebuhr MH, Jacobsen JD, et al. · Scand J Urol · 2014
Other devices of this type
Also filed under product code MEQ.
- Urologix Targis SystemUrologix, LLC · PMA 2015
- Prolieve Thermodilatation SystemMedifocus, Inc. · PMA 2007
- TMX-2000 BphBoston Scientific Corp · PMA 2004
- Prostalund Coretherm System and Prostaland Coretherm AccessoriesProstalund AB · PMA 2014
- Prolieve Thermodilitation SystemMedifocus, Inc. · PMA 2011
- ProstatronUrologix, Inc. · PMA 2005
- Prolieve Thermodilation SystemMedifocus, Inc. · PMA 2018
- Urologix Prostatron SystemUrologix, Inc. · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.